Patents by Inventor Menno Cornelis Franciscus Monnee
Menno Cornelis Franciscus Monnee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10766898Abstract: The invention provides compounds of Formula XXIII: wherein R1 is hydrogen, alkyl, acyl, or silyl, R2 is hydrogen, alkyl, benzyl, acyl, or ester, and R3 is hydrogen, alkyl, an aromatic group, azacyclic, carbocycle, aryl, cycloalkyl, heterocycloalkyl, heterocycle, heteroaryl, heteroalkyl, acyl, or ester, as well as derivatives and stereoisomers, pharmaceutically acceptable salts and derivatives thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.Type: GrantFiled: December 17, 2018Date of Patent: September 8, 2020Assignee: Janssen Pharmaceutica NVInventors: Bart DeCorte, Jacob Cornelis Russcher, Menno Cornelis Franciscus Monnee
-
Patent number: 10358448Abstract: The invention provides compounds of Formula 1: and stereoisomers, pharmaceutically acceptable salts and derivatives thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.Type: GrantFiled: July 24, 2018Date of Patent: July 23, 2019Assignee: Janssen Pharmaceutica NVInventors: Bart DeCorte, Jacob Cornelis Russcher, Menno Cornelis Franciscus Monnee
-
Patent number: 10351566Abstract: The invention provides compounds of Formula 1: and stereoisomers, pharmaceutically acceptable salts and derivatives thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.Type: GrantFiled: July 24, 2018Date of Patent: July 16, 2019Assignee: Janssen Pharmaceutica NVInventors: Bart DeCorte, Jacob Cornelis Russcher, Menno Cornelis Franciscus Monnee
-
Patent number: 10351565Abstract: The invention provides compounds of Formula 1: and stereoisomers, pharmaceutically acceptable salts and derivatives thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.Type: GrantFiled: June 11, 2018Date of Patent: July 16, 2019Assignee: Janssen Pharmaceutica NVInventors: Bart DeCorte, Jacob Cornelis Russcher, Menno Cornelis Franciscus Monnee
-
Publication number: 20190112311Abstract: The invention provides compounds of Formula XXIII: wherein R1 is hydrogen, alkyl, acyl, or silyl, R2 is hydrogen, alkyl, benzyl, acyl, or ester, and R3 is hydrogen, alkyl, an aromatic group, azacyclic, carbocycle, aryl, cycloalkyl, heterocycloalkyl, heterocycle, heteroaryl, heteroalkyl, acyl, or ester, as well as derivatives and stereoisomers, pharmaceutically acceptable salts and derivatives thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.Type: ApplicationFiled: December 17, 2018Publication date: April 18, 2019Applicant: Janssen Pharmaceutica NVInventors: Bart DeCorte, Jacob Cornelis Russcher, Menno Cornelis Franciscus Monnee
-
Patent number: 10155762Abstract: The invention provides compounds of Formula XXIII: wherein R1 is hydrogen, alkyl, acyl, or silyl, R2 is hydrogen, alkyl, benzyl, acyl, or ester, and R3 is hydrogen, alkyl, an aromatic group, azacyclic, carbocycle, aryl, cycloalkyl, heterocycloalkyl, heterocycle, heteroaryl, heteroalkyl, acyl, or ester, as well as derivatives and stereoisomers, pharmaceutically acceptable salts and derivatives thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.Type: GrantFiled: September 1, 2016Date of Patent: December 18, 2018Assignee: Janssen Pharmaceutica NVInventors: Bart DeCorte, Jacob Cornelis Russcher, Menno Cornelis Franciscus Monnee
-
Publication number: 20180327406Abstract: The invention provides compounds of Formula 1: and stereoisomers, pharmaceutically acceptable salts and derivatives thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.Type: ApplicationFiled: July 24, 2018Publication date: November 15, 2018Applicant: JANSSEN PHARMACEUTICA NVInventors: Bart DeCorte, Jacob Cornelis Russcher, Menno Cornelis Franciscus Monnee
-
Publication number: 20180327405Abstract: The invention provides compounds of Formula 1: and stereoisomers, pharmaceutically acceptable salts and derivatives thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.Type: ApplicationFiled: July 24, 2018Publication date: November 15, 2018Applicant: JANSSEN PHARMACEUTICA NVInventors: Bart DeCorte, Jacob Cornelis Russcher, Menno Cornelis Franciscus Monnee
-
Publication number: 20180291024Abstract: The invention provides compounds of Formula 1: and stereoisomers, pharmaceutically acceptable salts and derivatives thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.Type: ApplicationFiled: June 11, 2018Publication date: October 11, 2018Inventors: Bart DeCorte, Jacob Cornelis Russcher, Menno Cornelis Franciscus Monnee
-
Patent number: 10040797Abstract: The invention provides compounds of Formula 1: or a stereoisomer, pharmaceutically acceptable salt, or mixture thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.Type: GrantFiled: September 1, 2016Date of Patent: August 7, 2018Assignee: Janssen Pharmaceutica NVInventors: Bart DeCorte, Jacob Cornelis Russcher, Menno Cornelis Franciscus Monnee
-
Patent number: 10040796Abstract: The invention provides compounds of Formula 1: and stereoisomers, pharmaceutically acceptable salts and derivatives thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.Type: GrantFiled: September 1, 2016Date of Patent: August 7, 2018Assignee: Janssen Pharmaceutica NVInventors: Bart DeCorte, Jacob Cornelis Russcher, Menno Cornelis Franciscus Monnee
-
Patent number: 10040795Abstract: The invention provides compounds of Formula 1: and stereoisomers, pharmaceutically acceptable salts and derivatives thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.Type: GrantFiled: September 1, 2016Date of Patent: August 7, 2018Assignee: Janssen Pharmaceutica NVInventors: Bart DeCorte, Jacob Cornelis Russcher, Menno Cornelis Franciscus Monnee
-
Patent number: 9994572Abstract: The invention provides compounds of Formula 1: and stereoisomers, pharmaceutically acceptable salts and derivatives thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.Type: GrantFiled: September 1, 2016Date of Patent: June 12, 2018Assignee: Janssen Pharmaceutica NVInventors: Bart DeCorte, Jacob Cornelis Russcher, Menno Cornelis Franciscus Monnee
-
Publication number: 20170066767Abstract: The invention provides compounds of Formula 1: and stereoisomers, pharmaceutically acceptable salts and derivatives thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.Type: ApplicationFiled: September 1, 2016Publication date: March 9, 2017Inventors: Bart DeCorte, Jacob Cornelis Russcher, Menno Cornelis Franciscus Monnee
-
Publication number: 20170066770Abstract: The invention provides compounds of Formula XXIII: wherein R1 is hydrogen, alkyl, acyl, or silyl, R2 is hydrogen, alkyl, benzyl, acyl, or ester, and R3 is hydrogen, alkyl, an aromatic group, azacyclic, carbocycle, aryl, cycloalkyl, heterocycloalkyl, heterocycle, heteroaryl, heteroalkyl, acyl, or ester, as well as derivatives and stereoisomers, pharmaceutically acceptable salts and derivatives thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.Type: ApplicationFiled: September 1, 2016Publication date: March 9, 2017Inventors: Bart DeCorte, Jacob Cornelis Russcher, Menno Cornelis Franciscus Monnee
-
Publication number: 20170066769Abstract: The invention provides compounds of Formula 1: and stereoisomers, pharmaceutically acceptable salts and derivatives thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.Type: ApplicationFiled: September 1, 2016Publication date: March 9, 2017Inventors: Bart DeCorte, Jacob Cornelis Russcher, Menno Cornelis Franciscus Monnee
-
Publication number: 20170066768Abstract: The invention provides compounds of Formula 1: and stereoisomers, pharmaceutically acceptable salts and derivatives thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.Type: ApplicationFiled: September 1, 2016Publication date: March 9, 2017Inventors: BART DECORTE, JACOB CORNELIS RUSSCHER, MENNO CORNELIS FRANCISCUS MONNEE
-
Publication number: 20170066760Abstract: The invention provides compounds of Formula 1: or a stereoisomer, pharmaceutically acceptable salt, or mixture thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.Type: ApplicationFiled: September 1, 2016Publication date: March 9, 2017Inventors: Bart DeCorte, Jacob Cornelis Russcher, Menno Cornelis Franciscus Monnee